Live
10x Genomics Blog10x Genomics (TXG) Is Up 14.6% After Analyst Upgrade Highlights AI-Scale Spatial Genomics Initiative - simplywall.st10x Genomics BlogA Look At 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo FinanceThermo FisherJB Capital LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat10x Genomics BlogWhy 10x Genomics (TXG) Is Up 14.6% After Analyst Upgrade And New AI Data Initiative - Yahoo FinanceAgilentProfitability Warning: 3 Firms with Growth and Efficiency Concerns in 2026 - News and Statistics - IndexBoxCellSenescence in cancer: Hallmarks, paradoxes, and therapeutic promiseAgilentAgilent Technologies (A) Valuation Check After New Cell Imaging And Cancer Diagnostic Milestones - simplywall.stThermo FisherPerpetual Ltd Has $157.65 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeatAgilentQuintet Private Bank Europe S.A. Has $1.26 Million Position in Agilent Technologies, Inc. $A - MarketBeatEndpoints NewsPharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and moreAgilentAgilent Technologies, Inc. (A) stock price, news, quote and history - uk.finance.yahoo.comAgilentEmpirical Financial Services LLC d.b.a. Empirical Wealth Management Has $1.70 Million Position in Agilent Technologies, Inc. $A - MarketBeat
BioPharma Dive Mar 20, 2026

Rhythm obesity drug wins broader use from FDA

Rhythm obesity drug wins broader use from FDA

Original
Body unavailable. Use the original source.

Directory

59 All